Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 History  





2 Licensed uses  





3 Mode of action  





4 Adverse effects  





5 References  





6 External links  














Pefloxacin






العربية
فارسی
Français
Italiano
Македонски
Oʻzbekcha / ўзбекча
Polski
Română
Русский
Српски / srpski
Srpskohrvatski / српскохрватски

Українська
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Pefloxacin
Clinical data
ATC code
Pharmacokinetic data
Bioavailability100%
Protein binding20–30%
MetabolismHepatic
Elimination half-life8.6 hours
ExcretionMostly renal, also biliary
Identifiers
  • 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid

CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.067.807 Edit this at Wikidata
Chemical and physical data
FormulaC17H20FN3O3
Molar mass333.363 g·mol−1
3D model (JSmol)
  • O=C(O)\C2=C\N(c1cc(c(F)cc1C2=O)N3CCN(C)CC3)CC

  • InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24) checkY

  • Key:FHFYDNQZQSQIAI-UHFFFAOYSA-N checkY

  (verify)

Pefloxacin is a quinolone antibiotic used to treat bacterial infections. Pefloxacin has not been approved for use in the United States.

History

[edit]

Pefloxacin was developed in 1979 and approved in France for human use in 1985.[1]

Licensed uses

[edit]

Pefloxacin has been increasingly used as a veterinary medicine to treat microbial infections.[4]

Mode of action

[edit]

Pefloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It functions by inhibiting DNA gyrase, a type II topoisomerase, and topoisomerase IV,[5] which is an enzyme necessary to separate, replicated DNA, thereby inhibiting cell division.

Adverse effects

[edit]

Tendinitis and rupture, usually of the Achilles tendon, are class-effects of the fluoroquinolones, most frequently reported with pefloxacin.[6] The estimated risk of tendon damage during pefloxacin therapy has been estimated by the French authorities in 2000 to be 1 case per 23,130 treatment days as compared to ciprofloxacin where it has been estimated to be 1 case per 779,600.[7]

References

[edit]
  1. ^ Generics (UK) Limited v. Daiichi Pharmaceutical Co. Ltd & Daiichi Sankyo Co. Ltd, 2016-07-13 (EWHC 15 October 2008), Text.
  • ^ a b c "Reasons for prescribing Pefloxacin". pefloxacin.com. Archived from the original on 2016-03-05.
  • ^ Centers for Disease Control and Prevention (CDC) (April 2007). "Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections". MMWR Morb. Mortal. Wkly. Rep. 56 (14): 332–6. PMID 17431378.
  • ^ "Alternative uses for Pefloxacin". pefloxacin.com. Archived from the original on 2016-06-17.
  • ^ Drlica K, Zhao X (1 September 1997). "DNA gyrase, topoisomerase IV, and the 4-quinolones". Microbiol Mol Biol Rev. 61 (3): 377–92. doi:10.1128/mmbr.61.3.377-392.1997. PMC 232616. PMID 9293187.
  • ^ Khaliq Y, Zhanel GG (October 2005). "Musculoskeletal injury associated with fluoroquinolone antibiotics". Clin Plast Surg. 32 (4): 495–502, vi. doi:10.1016/j.cps.2005.05.004. PMID 16139623.
  • ^ Casparian JM, Luchi M, Moffat RE, Hinthorn D (May 2000). "Quinolones and tendon ruptures". South. Med. J. 93 (5): 488–91. doi:10.1097/00007611-200093050-00008. PMID 10832946.
  • [edit]
    Retrieved from "https://en.wikipedia.org/w/index.php?title=Pefloxacin&oldid=1174666780"

    Categories: 
    1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acids
    Fluoroquinolone antibiotics
    Piperazines
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
    ECHA InfoCard ID from Wikidata
    Drugs with no legal status
    Drugboxes which contain changes to watched fields
    All articles with dead external links
    Articles with dead external links from May 2020
    Articles with permanently dead external links
     



    This page was last edited on 9 September 2023, at 23:34 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki